» Articles » PMID: 18570056

Beneficial Effects of Testosterone Administration on Symptoms of the Lower Urinary Tract in Men with Late-onset Hypogonadism: a Pilot Study

Overview
Journal Aging Male
Specialty Geriatrics
Date 2008 Jun 24
PMID 18570056
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Elderly men are bothered by lower urinary tract complaints designated as lower urinary tract symptoms (LUTS). In epidemiological studies LUTS appears strongly associated with erectile dysfunction, and also with metabolic syndrome. LUTS occurs at an age at which plasma testosterone levels decline, in some men to hypogonadal values. Objectives. This pilot study tested whether testosterone administration to elderly men complaining of LUTS and whose plasma testosterone levels are below normal, might alleviate LUTS.

Methods: Group 1 (n = 10) received treatment with testosterone gel (50 mg) daily for three months; group 2 (n = 20) received treatment with injections of testosterone undecanoate 1000 mg for 26 weeks.

Results: Upon these interventions, plasma testosterone increased to the normal range. Symptoms of LUTS, measured by the International Prostate Symptoms Score, improved significantly, and also scores of the Aging Males' Symptoms scale and international index of erectile function improved. There were no untoward effects on the prostate over this period of time of the study.

Conclusion: Testosterone administration improved symptoms of LUTS in men with late-onset hypogonadism. The mechanism of action is as yet not understood, but it may be connected with or parallel with the effects of testosterone on penile tissues in hypogonadal men, such as on nitric oxide and phosphodiesterase.

Citing Articles

Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia.

Lin L, Wang W, Xiao K, Guo X, Zhou L J Endocrinol Invest. 2023; 46(10):2095-2102.

PMID: 36913135 DOI: 10.1007/s40618-023-02060-0.


Hypogonadism and urologic surgeries: a narrative review.

Fendereski K, Ghaed M, Calvert J, Hotaling J Transl Androl Urol. 2022; 11(7):1045-1062.

PMID: 35958902 PMC: 9360521. DOI: 10.21037/tau-22-308.


Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A.

Grober E, Krakowsky Y, Khera M, Holmes D, Lee J, Grantmyre J Can Urol Assoc J. 2021; 15(5):E234-E243.

PMID: 33661092 PMC: 8095276. DOI: 10.5489/cuaj.7252.


Correlation Between Testosterone Replacement Treatment and Lower Urinary Tract Symptoms.

Lee M, Shin Y, Kam S Int Neurourol J. 2021; 25(1):12-22.

PMID: 33504130 PMC: 8022167. DOI: 10.5213/inj.2040234.117.


Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.

Saad F, Doros G, Haider K, Haider A Investig Clin Urol. 2018; 59(6):399-409.

PMID: 30402573 PMC: 6215782. DOI: 10.4111/icu.2018.59.6.399.